Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAL American Airlines Group	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Didora Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.17	$12.00 ➝ $13.00	Neutral ➝ Neutral
ABEO Abeona Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.91 -3.1%	$20.00	Buy ➝ Buy
ABF Associated British Foods	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 2,304 +1.3%		Buy
ABSI Absci	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vikram Purohit Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.83 -3.4%	$6.40 ➝ $5.89	Overweight ➝ Overweight
ACTU Actuate Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.25 +1.6%	$20.00	Buy ➝ Buy
AFL Aflac	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the recommendation accuracy rating	$105.77 +0.4%	$108.00 ➝ $113.00	Equal Weight ➝ Equal Weight
AHR American Healthcare REIT	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Lewis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.91 +1.1%	$38.00 ➝ $44.00	Buy ➝ Buy
AI Atrium Mortgage Investment	Target Set by	Fundamental Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$11.70 +0.3%	C$12.98	Buy
AII American Integrity Insurance Group	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gregory Peters Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.71 -1.9%	$20.00 ➝ $22.00	Outperform ➝ Outperform
AIZ Assurant	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$209.53 -1.4%		Cautious ➝ Cautious
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
AIZ Assurant	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$209.53 -1.4%	$218.00 ➝ $230.00	Equal Weight ➝ Equal Weight
ALB Albemarle	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Zekauskas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$83.27 +1.3%	$60.00 ➝ $80.00	Neutral ➝ Neutral
ALGS Aligos Therapeutics	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Patrick R. Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.77 +13.9%	$50.00	Buy
ALTG Alta Equipment Group	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matt Summerville Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.73 -3.6%	$8.00	Buy ➝ Neutral
AM Antero Midstream	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Mackay Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.53 -2.1%	$15.50 ➝ $17.50	Neutral ➝ Neutral
AMRC Ameresco	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jon Windham	$22.72 +6.0%	$11.00 ➝ $23.00	Sell ➝ Neutral
AMT American Tower	Reiterated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the recommendation accuracy rating	$202.95 -1.5%	$246.00 ➝ $250.00	Overweight ➝ Overweight
AMTM Amentum	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Gesuale	$25.12 -0.2%	$30.00	Outperform ➝ Outperform
AMTM Amentum	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Trevor Walsh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.12 -0.2%	$30.00	Market Outperform ➝ Market Outperform
ANRO Alto Neuroscience	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Patrick R. Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.40 +8.4%	$10.00	Buy ➝ Buy
AON AON	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Phillips Subscribe to MarketBeat All Access for the recommendation accuracy rating	$365.96 -0.3%		Cautious ➝ Cautious
AON AON	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Phillips Subscribe to MarketBeat All Access for the recommendation accuracy rating	$365.96 -0.3%	$365.00 ➝ $385.00	Equal Weight ➝ Equal Weight
APA APA	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Devin McDermott	$20.41 -0.3%	$22.00 ➝ $23.00	Underweight ➝ Underweight
APLD Applied Digital	Target Raised by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.34 +16.0%	$12.00 ➝ $23.00	Buy ➝ Buy
APR.UN Automotive Properties Real Est Invt TR	Target Raised by	Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$11.59 +0.4%	C$12.00 ➝ C$13.00	Buy
AR Antero Resources	Downgraded by	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Leo Mariani	$30.13 -5.8%	$44.00 ➝ $32.00	Buy ➝ Neutral
ARES Ares Management	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kenneth S. Lee	$189.82 +1.1%	$195.00 ➝ $215.00	Outperform ➝ Outperform
ARIS Aris Water Solutions	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Bandel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.70 -1.0%	$26.00 ➝ $25.00	In-Line ➝ In-Line
ASC ASOS	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 313.50 +2.1%		Buy
ASMB Assembly Biosciences	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Patrick Trucchio Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.76 +1.3%	$50.00	Buy
AVAV AeroVironment	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Trevor Walsh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$247.13 +0.2%	$325.00	Market Outperform ➝ Market Outperform
AVPT AvePoint	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.21 +1.2%	$19.00 ➝ $18.00	Neutral ➝ Neutral
AZO AutoZone	Reiterated by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Greg Melich	$4,045.32 +1.0%	$4,060.00 ➝ $4,250.00	Outperform ➝ Outperform
BAB Babcock International Group	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 986.50 -5.8%	GBX 1,200	Outperform
BCAX Bicara Therapeutics	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.47 -1.5%		Overweight
BDT Bird Construction	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$23.85 -2.7%	C$35.00 ➝ C$33.00
BDT Bird Construction	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$23.85 -2.7%	C$34.00 ➝ C$31.00	Buy
BJ BJ's Wholesale Club	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the recommendation accuracy rating	$104.96 +1.7%	$130.00 ➝ $120.00	Buy ➝ Buy
BNGO Bionano Genomics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yi Chen	$3.15 +3.6%	$10.00 ➝ $11.00	Buy ➝ Buy
BOW Bowhead Specialty	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$30.24 -1.3%	$37.00 ➝ $34.00	Equal Weight ➝ Equal Weight
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly.
BP BP	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Todd Subscribe to MarketBeat All Access for the recommendation accuracy rating	$34.06 -0.8%	$35.00 ➝ $38.00	Neutral ➝ Neutral
BRAG Bragg Gaming Group	Downgraded by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Hickey	$2.91 -0.7%	$6.00	Buy ➝ Hold
BRBR BellRing Brands	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Baumgartner Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.50 +0.4%	$75.00 ➝ $45.00	Outperform ➝ Outperform
BRO Brown & Brown	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$95.01 -0.3%	$109.00 ➝ $105.00	Equal Weight ➝ Equal Weight
BRZE Braze	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Macwilliams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.55 +4.1%	$43.00 ➝ $35.00	Overweight ➝ Overweight
BTBT Bit Digital	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Dede Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.94 -2.3%	$7.00	Buy ➝ Buy
BTDR Bitdeer Technologies Group	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Colonnese Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.36 +7.2%	$18.00 ➝ $19.00	Buy ➝ Buy
BVC BATM Advanced Communications	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 14.80 +0.3%		House Stock
BWY Bellway	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 2,448 +0.8%	GBX 3,200 ➝ GBX 2,900	Hold
CB Chubb	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$272.81 -0.5%	$300.00 ➝ $295.00	Equal Weight ➝ Equal Weight
CBG Close Brothers Group	Downgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 492.44 -1.2%	GBX 525	Sector perform
CCB Coastal Financial	Reiterated by	Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brett Rabatin	$105.95 -1.5%	$129.00	Outperform ➝ Outperform
CCB Coastal Financial	Target Set by	Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brett Rabatin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$105.95 -1.5%	$126.00
CCI Crown Castle	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brendan Lynch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$100.48 -1.2%	$121.00 ➝ $119.00	Overweight ➝ Overweight
CCOI Cogent Communications	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Luebchow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.90 +7.7%	$45.00	Underweight ➝ Overweight
CELC Celcuity	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$51.57 -0.4%	$50.00 ➝ $66.00	Buy ➝ Buy
CELU Celularity	Initiated by	WBB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steve Brozak Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.15 +19.3%	$6.00	Speculative Buy
CFF Conifex Timber	Target Lowered by	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$0.31 -3.2%	C$0.85 ➝ C$0.75	Market Perform
CGEM Cullinan Therapeutics	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Hung Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.95 +3.8%	$35.00 ➝ $28.00	Overweight ➝ Overweight
CGON CG Oncology	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.13 +1.7%		Overweight
CHE.UN Chemtrade Logistics Income Fund	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$12.70 +3.8%	C$15.00 ➝ C$16.00
CHE.UN Chemtrade Logistics Income Fund	Target Raised by	Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$12.70 +3.8%	C$15.50 ➝ C$16.00	Buy
CHKP Check Point Software Technologies	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$188.64 -0.1%	$230.00 ➝ $200.00	Neutral ➝ Neutral
CIVB Civista Bancshares	Downgraded by	Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brendan Nosal	$19.89 -0.6%	$22.00	Outperform ➝ Market Perform
CLNN Clene	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sumant Kulkarni Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.24 +17.1%	$83.00 ➝ $48.00	Buy ➝ Buy
CMPO CompoSecure	Reiterated by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Hal Goetsch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.74 +0.9%	$17.00 ➝ $23.00	Buy ➝ Buy
COLD Americold Realty Trust	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Carroll Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.30 -3.7%	$25.00 ➝ $19.00	Outperform ➝ Outperform
COP ConocoPhillips	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Todd Subscribe to MarketBeat All Access for the recommendation accuracy rating	$94.00 -1.4%	$123.00 ➝ $124.00	Overweight ➝ Overweight
CORZ Core Scientific	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jonathan Petersen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.53 +2.8%	$16.00 ➝ $22.00	Buy ➝ Buy
COTY Coty	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nik Modi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.98 +1.2%	$12.00	Outperform ➝ Outperform
CPB Campbell's	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Megan Alexander Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.34 -0.5%	$35.00 ➝ $32.00	Equal Weight ➝ Equal Weight
CRCL Circle Internet Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$141.45 -5.2%	$247.00	Buy ➝ Buy
CRK Comstock Resources	Downgraded by	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Leo Mariani	$15.01 -5.8%	$18.00 ➝ $12.00	Neutral ➝ Sell
CRM Salesforce	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$244.15 +0.7%	$347.00 ➝ $316.00	Overweight ➝ Overweight
CRM Salesforce	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the recommendation accuracy rating	$244.15 +0.7%	$275.00	Sector Perform ➝ Sector Perform
CRM Salesforce	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the recommendation accuracy rating	$244.15 +0.7%	$300.00 ➝ $260.00	Neutral ➝ Neutral
CRVO CervoMed	Target Raised by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.83 -2.9%	$15.00 ➝ $31.00	Buy ➝ Buy
CRWD CrowdStrike	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Levine	$426.34 -0.4%	$440.00 ➝ $425.00	In-Line ➝ In-Line
CRZBY Commerzbank	Downgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.11 -3.4%		Buy ➝ Hold
CSX CSX	Downgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fadi Chamoun Subscribe to MarketBeat All Access for the recommendation accuracy rating	$35.99 -0.9%	$38.00	Outperform ➝ Market Perform
CTBI Community Trust Bancorp	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.49 +2.6%	$66.00	Overweight
CTNM Contineum Therapeutics	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Hung Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.10 +9.8%	$20.00 ➝ $21.00	Overweight ➝ Overweight
CURI CuriosityStream	Initiated by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.21 +4.5%	$7.00	Buy
CVE Cenovus Energy	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$20.66 -0.5%	C$24.00 ➝ C$25.00
CVS CVS Health	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$70.12 +2.2%	$67.00 ➝ $79.00	Neutral ➝ Buy
CVX Chevron	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Todd	$155.44 -0.7%	$164.00 ➝ $168.00	Overweight ➝ Overweight
CXT Crane NXT	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matt Summerville Subscribe to MarketBeat All Access for the recommendation accuracy rating	$60.31 +1.1%	$85.00	Buy ➝ Buy
DAVE Dave	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gary Prestopino Subscribe to MarketBeat All Access for the recommendation accuracy rating	$202.30 +0.5%	$290.00	Outperform ➝ Outperform
DAWN Day One Biopharmaceuticals	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.81 +0.9%		Overweight ➝ Overweight
DDOG Datadog	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fatima Boolani	$129.07 +1.4%	$165.00 ➝ $170.00	Buy ➝ Buy
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly.
DE Deere & Company	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Shlisky Subscribe to MarketBeat All Access for the recommendation accuracy rating	$490.83 +0.4%	$595.00 ➝ $580.00	Buy ➝ Buy
DKS DICK'S Sporting Goods	Reiterated by	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$223.50 -0.2%		Hold ➝ Hold
DNLI Denali Therapeutics	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Harrison Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.82 +0.8%	$33.00 ➝ $30.00	Overweight ➝ Overweight
DNN Denison Mine	Reiterated by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.06 +1.5%		Outperform ➝ Outperform
DNN Denison Mine	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.06 +1.5%		Outperform ➝ Outperform
DT Dynatrace	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$48.80 +1.2%	$68.00 ➝ $64.00	Buy ➝ Buy
DUOL Duolingo	Upgraded by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Justin Patterson	$369.19 +12.9%	$460.00	Sector Weight ➝ Overweight
DUOL Duolingo	Initiated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ygal Arounian	$369.19 +12.9%	$400.00	Buy
DVN Devon Energy	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Devin McDermott	$33.54 -0.4%	$46.00 ➝ $49.00	Overweight ➝ Overweight
DY Dycom Industries	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Luebchow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$273.11 +1.4%	$250.00 ➝ $295.00	Overweight ➝ Overweight
EL Estee Lauder Companies	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Susan Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$90.85 -0.1%	$62.00 ➝ $85.00	Hold ➝ Hold
ENLV Enlivex Therapeutics	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.25 -31.3%	$13.00	Buy ➝ Buy
EPAM EPAM Systems	Upgraded by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$164.62 +4.4%	$205.00	Hold ➝ Buy
EPAM EPAM Systems	Upgraded by	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$164.62 +4.4%		Hold ➝ Buy
EQH Equitable	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the recommendation accuracy rating	$53.05 -1.6%	$68.00 ➝ $67.00	Overweight ➝ Overweight
EQT EQT	Downgraded by	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Leo Mariani	$50.56 -4.3%	$75.00 ➝ $57.00	Buy ➝ Neutral
ERAS Erasca	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Hung Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.53 -6.7%	$4.00 ➝ $2.00	Overweight ➝ Equal Weight
ETOR eToro Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$47.63 -1.1%	$78.00	Buy ➝ Buy
EXE Expand Energy	Downgraded by	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Leo Mariani	$93.03 -2.2%	$125.00 ➝ $98.00	Buy ➝ Neutral
FANG Diamondback Energy	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Devin McDermott	$139.52 -0.5%	$184.00 ➝ $186.00	Overweight ➝ Overweight
FBRX Forte Biosciences	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yatin Suneja	$11.91 +2.9%	$75.00	Buy
FCFS FirstCash	Reiterated by	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$138.45 +1.4%		Buy ➝ Buy
FDX FedEx	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ariel Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$227.72 +0.2%	$278.00 ➝ $275.00	Buy ➝ Buy
FICO Fair Isaac	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Griffin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1,352.66 +0.7%	$1,650.00 ➝ $1,800.00	Outperform ➝ Outperform
FICO Fair Isaac	Target Set by	Griffin Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Griffin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1,352.66 +0.7%	$1,800.00
FLO Flowers Foods	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Holland Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.75 +0.4%	$15.00	Neutral ➝ Neutral
FLO Flowers Foods	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bill Chappell Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.75 +0.4%	$20.00 ➝ $15.00	Hold ➝ Hold
FTCI FTC Solar	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jon Windham	$5.93 +5.1%	$3.80 ➝ $5.50	Neutral ➝ Neutral
FTNT Fortinet	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fatima Boolani	$80.76 +2.1%	$110.00 ➝ $85.00	Neutral ➝ Neutral
GATX GATX	Target Set by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bascome Majors Subscribe to MarketBeat All Access for the recommendation accuracy rating	$158.14 +1.1%	$190.00	Neutral ➝ Positive
GBIO Generation Bio	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Whitney Ijem Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.63 +5.4%	$9.00 ➝ $10.00	Buy ➝ Buy
GENI Genius Sports	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Hickey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.95 +0.3%	$14.00 ➝ $15.00	Buy ➝ Buy
GL Globe Life	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$135.99 +0.4%	$166.00 ➝ $171.00	Overweight ➝ Overweight
GLOB Globant	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Schneider Subscribe to MarketBeat All Access for the recommendation accuracy rating	$68.32 +2.8%	$120.00 ➝ $105.00	Neutral ➝ Neutral
GWH ESS Tech	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ben Kallo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.62 -7.2%	$6.00 ➝ $2.00	Neutral ➝ Neutral
HALO Halozyme Therapeutics	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vikram Purohit Subscribe to MarketBeat All Access for the recommendation accuracy rating	$68.96 +2.5%	$75.00 ➝ $80.00	Overweight ➝ Overweight
HD Home Depot	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Carter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$394.68 -1.2%	$425.00 ➝ $432.00	Buy ➝ Buy
HEI Heico	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$307.69 -0.1%		Buy ➝ Buy
HG Hamilton Insurance Group	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.03 -1.4%		Cautious ➝ Cautious
HG Hamilton Insurance Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.03 -1.4%	$21.00 ➝ $23.00	Equal Weight ➝ Equal Weight
HIMS Hims & Hers Health	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jailendra Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$45.15 -1.9%	$48.00 ➝ $37.00	Hold ➝ Hold
HOLX Hologic	Upgraded by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$67.27 -0.8%	$80.00	Hold ➝ Buy
HOTH Hoth Therapeutics	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.29 +0.8%	$5.00	Buy ➝ Buy
HOV Hovnanian Enterprises	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jay McCanless Subscribe to MarketBeat All Access for the recommendation accuracy rating	$152.99 -1.9%	$120.00	Neutral ➝ Neutral
IRON Disc Medicine	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sean Laaman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$58.84 -1.7%	$85.00 ➝ $90.00	Overweight ➝ Overweight
JANX Janux Therapeutics	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.53 +1.7%		Overweight
JKHY Jack Henry & Associates	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Heckmann Subscribe to MarketBeat All Access for the recommendation accuracy rating	$160.83 +0.3%	$212.00	Buy ➝ Buy
JXN Jackson Financial	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the recommendation accuracy rating	$93.95 -0.5%	$92.00 ➝ $97.00	Equal Weight ➝ Equal Weight
KOD Kodiak Sciences	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.25 +6.4%	$3.00 ➝ $5.00	Neutral ➝ Neutral
KRC Kilroy Realty	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.20 -1.3%	$43.00 ➝ $42.00	In-Line ➝ In-Line
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly.
LDI loanDepot	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.88 -4.8%		Neutral
LI Li Auto	Initiated by	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.05 -0.6%		Outperform ➝ Underperform
LI Li Auto	Initiated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.05 -0.6%	$18.00	Underperform
LINE Lineage	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Carroll Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.39 -3.2%	$64.00 ➝ $51.00	Outperform ➝ Outperform
LITE Lumentum	Initiated by	KGI Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$118.98 +2.7%		Outperform
LMND Lemonade	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.69 +4.0%		Underweight ➝ Underweight
LMND Lemonade	Target Set by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jack Matten Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.69 +4.0%	$23.00 ➝ $42.00	Underperform ➝ Underperform
LNC Lincoln National	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.17 -1.0%	$38.00 ➝ $41.00	Equal Weight ➝ Equal Weight
LNC Lincoln National	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.17 -1.0%	$41.00
LODE Comstock	Downgraded by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Legg	$2.35 +0.9%	$12.00 ➝ $4.00	Buy ➝ Neutral
LOW Lowe's Companies	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	W. Andrew Subscribe to MarketBeat All Access for the recommendation accuracy rating	$250.86 -0.5%	$240.00 ➝ $265.00	Hold ➝ Hold
LULU lululemon athletica	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the recommendation accuracy rating	$203.62 +2.6%	$290.00 ➝ $240.00	Neutral ➝ Neutral
LULU lululemon athletica	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$203.62 +2.6%	$321.00 ➝ $298.00	Buy
LUNR Intuitive Machines	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.08 -0.1%		Buy ➝ Buy
LYV Live Nation Entertainment	Initiated by	Moffett Nathanson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Robert Fishman	$162.24 +0.8%	$195.00	Buy
MAIN Main Street Capital	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bryce Rowe Subscribe to MarketBeat All Access for the recommendation accuracy rating	$65.64 -0.7%	$60.00 ➝ $64.00	Neutral ➝ Neutral
MCB McCoy Global	Target Set by	Beacon Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$3.34 +2.5%	C$5.50	Buy
MDB MongoDB	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tyler Radke	$227.06 +4.0%	$395.00 ➝ $405.00	Buy ➝ Buy
MELI MercadoLibre	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joao Pedro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2,364.01 -1.2%	$2,900.00 ➝ $2,850.00	Buy ➝ Buy
MET MetLife	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the recommendation accuracy rating	$77.77 +0.6%	$98.00 ➝ $94.00	Overweight ➝ Overweight
MFC Manulife Financial	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$30.66 +0.9%	$48.00
MH McGraw Hill	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Faiza Alwy	$14.49 +8.5%	$18.00	Buy
MH McGraw Hill	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Silber	$14.49 +8.5%	$24.00	Outperform
MH McGraw Hill	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	George Tong	$14.49 +8.5%	$27.00	Buy
MH McGraw Hill	Initiated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Sheldon	$14.49 +8.5%		Outperform
MH McGraw Hill	Target Set by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.49 +8.5%	$19.00	Buy
MH McGraw Hill	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.49 +8.5%	$19.00	Buy
MH McGraw Hill	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Toni Kaplan	$14.49 +8.5%	$20.00	Overweight
MH McGraw Hill	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joshua Chan	$14.49 +8.5%	$15.00	Neutral
MH McGraw Hill	Initiated by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steve Koenig	$14.49 +8.5%	$19.00	Outperform
MH McGraw Hill	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shlomo Rosenbaum Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.49 +8.5%	$19.00	Buy
MH McGraw Hill	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Meuler Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.49 +8.5%	$21.00	Outperform
MH McGraw Hill	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Karnovsky Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.49 +8.5%	$21.00	Overweight
MH McGraw Hill	Initiated by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.49 +8.5%	$28.60	Buy
MMC Marsh & McLennan Companies	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Phillips Subscribe to MarketBeat All Access for the recommendation accuracy rating	$207.71 +0.2%	$225.00 ➝ $220.00	Equal Weight ➝ Equal Weight
MNDY monday.com	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$179.01 +1.9%	$250.00	Buy ➝ Buy
MOD Modine Manufacturing	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sangita Jain Subscribe to MarketBeat All Access for the recommendation accuracy rating	$139.50 +0.6%	$150.00 ➝ $160.00	Overweight ➝ Overweight
MSFT Microsoft	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Terry Tillman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$517.10 -0.6%	$650.00 ➝ $675.00	Buy ➝ Buy
MTDR Matador Resources	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$46.83 -0.2%	$60.00 ➝ $62.00	Equal Weight ➝ Equal Weight
NET Cloudflare	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fatima Boolani	$202.31 +0.7%	$240.00 ➝ $255.00	Buy ➝ Buy
NKE NIKE	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		$77.43 +0.6%		Outperform ➝ Outperform
NNE Nano Nuclear Energy	Downgraded by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Legg	$32.06 -10.7%	$51.00 ➝ $9.00	Buy ➝ Sell
NOG Northern Oil and Gas	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Devin McDermott	$23.79 -2.3%	$29.00 ➝ $27.00	Positive ➝ Underweight
NTES NetEase	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jiong Shao Subscribe to MarketBeat All Access for the recommendation accuracy rating	$130.30 +0.8%	$118.00 ➝ $120.00	Equal Weight ➝ Equal Weight
NU NU	Upgraded by	Itau BBA Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.33 +1.8%	$18.00	Market Perform ➝ Outperform
NVDA NVIDIA	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	C.J. Muse	$182.01 +0.9%	$200.00 ➝ $240.00	Overweight ➝ Overweight
NVDA NVIDIA	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the recommendation accuracy rating	$182.01 +0.9%	$200.00 ➝ $206.00	Overweight ➝ Overweight
NVDA NVIDIA	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$182.01 +0.9%		Overweight ➝ Overweight
NVTS Navitas Semiconductor	Downgraded by	CJS Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.77 -2.2%		Outperform ➝ Market Perform
NXT Nextracker	Upgraded by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Osha	$67.70 +11.8%	$74.00	Neutral ➝ Buy
The Coin That Could Define Trump’s Crypto Presidency (Ad) When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.” Discover the coin that could define Trump’s crypto presidency.
OKTA Okta	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the recommendation accuracy rating	$91.38 -0.7%	$120.00 ➝ $100.00	Equal Weight ➝ Equal Weight
OKTA Okta	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the recommendation accuracy rating	$91.38 -0.7%	$138.00	Buy ➝ Buy
OLLI Ollie's Bargain Outlet	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$133.81 +0.2%	$133.00 ➝ $144.00	Outperform ➝ Outperform
ORKA Oruka Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mitchell S. Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.25 -0.8%	$45.00	Buy ➝ Buy
OVV Ovintiv	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.11 -0.7%	$52.00 ➝ $48.00	Overweight ➝ Equal Weight
OXY Occidental Petroleum	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$44.27 -0.8%	$52.00	Overweight ➝ Equal Weight
PFG Principal Financial Group	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$77.70 +0.1%	$75.00 ➝ $77.00	Underweight ➝ Underweight
PR Permian Resources	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Devin McDermott	$13.31 -1.0%	$17.00 ➝ $18.00	Overweight ➝ Overweight
PRI Primerica	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$262.28 +0.2%	$292.00 ➝ $308.00	Equal Weight ➝ Equal Weight
PRLD Prelude Therapeutics	Target Lowered by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reni J. Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.94 +8.5%	$4.00 ➝ $3.00	Market Outperform ➝ Market Outperform
PROP Prairie Operating	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Lear Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.70 -1.8%		Overweight ➝ Neutral
PRU Prudential Financial	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the recommendation accuracy rating	$106.66 +0.7%	$113.00 ➝ $117.00	Equal Weight ➝ Equal Weight
PRV.UN PRO Real Estate Investment Trust	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$2.30 +0.4%	C$5.50 ➝ C$6.00	Hold
PSN Persimmon	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,121.50 +2.3%	GBX 1,450 ➝ GBX 1,300	Hold
PSTV Plus Therapeutics	Target Lowered by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason McCarthy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.54 -14.6%	$4.00 ➝ $3.00	Buy ➝ Buy
RAL Ralliant	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.27 -0.5%		Sector Perform
RBLX Roblox	Reiterated by	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$120.01 +2.3%		Sell ➝ Sell
RDDT Reddit	Initiated by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$241.76 -1.9%	$250.00	Buy
RDW Redwire	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ronald Epstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.02 +0.9%	$10.00	Underperform
RGA Reinsurance Group of America	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the recommendation accuracy rating	$187.62 -0.3%	$210.00 ➝ $195.00	Equal Weight ➝ Equal Weight
RKT Rocket Companies	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.83 -3.8%		Buy
ROOT Root	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Meredith	$88.05 -2.6%	$140.00 ➝ $105.00	Neutral ➝ Neutral
ROST Ross Stores	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$146.06 -0.6%	$150.00	Market Perform ➝ Market Perform
RPD Rapid7	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.46 +0.9%	$35.00 ➝ $30.00	Buy ➝ Buy
RRC Range Resources	Downgraded by	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Leo Mariani	$33.09 -3.8%	$44.00 ➝ $35.00	Buy ➝ Neutral
RSKD Riskified	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Clarke Jeffries Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.43 -15.9%	$7.00 ➝ $6.00	Overweight ➝ Overweight
RUN Sunrun	Upgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Dendrinos	$15.50 +11.4%	$12.00 ➝ $16.00	Sector Perform ➝ Outperform
RVMD Revolution Medicines	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.45 +0.4%		Overweight ➝ Overweight
RVMD Revolution Medicines	Initiated by	Lifesci Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.45 +0.4%	$80.00	Outperform
RVPH Reviva Pharmaceuticals	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.52 -3.9%	$3.00	Buy ➝ Buy
RVPH Reviva Pharmaceuticals	Reiterated by	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boobalan Pachaiyappan	$0.52 -3.9%	$7.00 ➝ $3.00	Buy ➝ Buy
RYAN Ryan Specialty	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.00 -0.2%	$71.00 ➝ $68.00	Overweight ➝ Overweight
SDGR Schrodinger	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vikram Malhorta Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.05 +3.5%	$28.00 ➝ $19.00	Equal Weight ➝ Equal Weight
SEGXF SEGRO	Downgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.41 -5.0%		Overweight ➝ Underweight
SHCO Soho House & Co Inc.	Downgraded by	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.79 +15.0%		Neutral
SHEL Shell	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Todd Subscribe to MarketBeat All Access for the recommendation accuracy rating	$71.52 -0.5%	$84.00 ➝ $82.00	Overweight ➝ Overweight
SJM J. M. Smucker	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris Carey	$111.53 +0.7%	$115.00 ➝ $120.00	Overweight ➝ Overweight
SJM J. M. Smucker	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Megan Alexander Subscribe to MarketBeat All Access for the recommendation accuracy rating	$111.53 +0.7%	$115.00 ➝ $118.00	Overweight ➝ Overweight
SLDE Slide Insurance	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.54 -0.1%	$19.00 ➝ $18.00	Equal Weight ➝ Equal Weight
SLDE Slide Insurance	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Jian Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.54 -0.1%		Cautious ➝ Cautious
SLG SL Green Realty	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$54.09 -0.3%	$74.00 ➝ $73.00	Outperform ➝ Outperform
SLNO Soleno Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raghuram Selvaraju	$68.09 -4.9%	$100.00 ➝ $110.00	Buy ➝ Buy
SMMT Summit Therapeutics	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.29 -1.5%		Neutral
SMTI Sanara MedTech	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.58 +6.4%	$53.00 ➝ $54.00	Buy ➝ Buy
SMTI Sanara MedTech	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.58 +6.4%	$53.00 ➝ $54.00	Buy ➝ Buy
SMWB Similarweb	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Wong Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.77 +3.7%	$13.00 ➝ $14.00	Outperform ➝ Outperform
SNN Smith & Nephew SNATS	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Caitlin Cronin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.29 +0.2%	$28.00 ➝ $36.00	Hold ➝ Hold
SPOT Spotify Technology	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Helfstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$728.06 -0.6%	$750.00 ➝ $825.00	Outperform ➝ Outperform
SPOT Spotify Technology	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Morris Subscribe to MarketBeat All Access for the recommendation accuracy rating	$728.06 -0.6%	$800.00 ➝ $850.00	Buy ➝ Buy
SPT Spirent Communications	Downgraded by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 196.20 -0.1%	GBX 199	Hold
SRFM Surf Air Mobility	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Austin Moeller Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.39 -0.9%	$3.00 ➝ $3.75	Hold ➝ Hold
SSTY Safestay	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 22.50 -2.2%		House Stock
STB Secure Trust Bank	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,165 +1.3%	GBX 1,420	Buy
STOK Stoke Therapeutics	Target Set by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thomas Shrader Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.51 +1.6%	$28.00	Buy ➝ Buy
SU Suncor Energy	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$53.27 -0.8%	C$53.00 ➝ C$57.00
SWK Stanley Black & Decker	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jonathan Matuszewski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$74.69 +0.9%	$86.00	Buy ➝ Buy
SYNA Synaptics	Initiated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tom O'Malley	$70.12 +5.0%	$78.00	Overweight
TEAM Atlassian	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fatima Boolani	$169.17 +1.3%	$300.00 ➝ $240.00	Buy ➝ Buy
TGEN Tecogen	Initiated by	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chip Moore	$9.52 +14.8%	$15.00	Buy
TLO Talon Metals	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$0.39 -3.7%	C$0.35 ➝ C$0.50	Buy
TM Toyota Motor	Upgraded by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		$197.85 +2.2%		Market Perform ➝ Outperform
TMC TMC the metals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Heiko F. Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.79 -2.6%	$7.25	Buy ➝ Buy
TMO Thermo Fisher Scientific	Initiated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$488.15 -0.2%		Outperform
TNGX Tango Therapeutics	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.22 +6.6%		Overweight ➝ Overweight
TOL Toll Brothers	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the recommendation accuracy rating	$131.31 +0.6%	$140.00 ➝ $150.00	Overweight ➝ Overweight
TRIP TripAdvisor	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ronald Josey	$16.72 -5.1%	$16.00 ➝ $19.00	Neutral ➝ Neutral
TTAN ServiceTitan	Upgraded by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yun Kim	$107.24 +3.4%	$100.00 ➝ $140.00	Hold ➝ Buy
TTE TotalEnergies	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Todd Subscribe to MarketBeat All Access for the recommendation accuracy rating	$61.63 -1.0%	$66.00 ➝ $68.00	Neutral ➝ Neutral
TTEC TeleTech	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vincent A. Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.74 +3.6%		Market Perform ➝ Market Perform
TVGN Tevogen Bio	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.96 +1.6%	$10.00	Buy ➝ Buy
TWFG TWFG	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.87 -2.2%	$35.00 ➝ $32.00	Equal Weight ➝ Equal Weight
ULTA Ulta Beauty	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$516.87 -0.8%		Neutral ➝ Neutral
UNH UnitedHealth Group	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Fischbeck Subscribe to MarketBeat All Access for the recommendation accuracy rating	$308.84 +1.6%	$290.00 ➝ $325.00	Neutral ➝ Neutral
UNM Unum Group	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the recommendation accuracy rating	$68.57 -0.4%	$85.00 ➝ $79.00	Equal Weight ➝ Equal Weight
URGN Urogen Pharma	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.40 -1.6%		Overweight
VCTR Victory Capital	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Cyprys Subscribe to MarketBeat All Access for the recommendation accuracy rating	$70.91 -0.5%	$66.00 ➝ $67.00	Equal Weight ➝ Equal Weight
VNOM Viper Energy	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Devin McDermott	$37.24 -1.5%	$46.00	Overweight
VOYA Voya Financial	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$73.93 -0.1%	$89.00 ➝ $90.00	Overweight ➝ Overweight
VRNS Varonis Systems	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$58.49 +0.1%	$51.00 ➝ $58.00	Neutral ➝ Neutral
WDAY Workday	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$231.85 +2.5%	$321.00 ➝ $298.00	Overweight ➝ Overweight
WDAY Workday	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$231.85 +2.5%	$325.00 ➝ $300.00	Overweight ➝ Overweight
WIX Wix.com	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$128.77 +3.6%		Outperform ➝ Outperform
WIX Wix.com	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Boone Subscribe to MarketBeat All Access for the recommendation accuracy rating	$128.77 +3.6%	$160.00 ➝ $200.00	Market Outperform ➝ Market Outperform
WMT Walmart	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Heinbockel	$100.65 +0.7%	$112.00 ➝ $115.00	Buy ➝ Buy
WMT Walmart	Reiterated by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Greg Melich Subscribe to MarketBeat All Access for the recommendation accuracy rating	$100.65 +0.7%	$108.00 ➝ $110.00	Outperform ➝ Outperform
WT WisdomTree	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Cyprys Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.67 +1.9%	$11.50 ➝ $12.50	Equal Weight ➝ Equal Weight
WTW Willis Towers Watson Public	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vincent Sinisi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$329.59 -0.3%	$335.00 ➝ $345.00	Equal Weight ➝ Equal Weight
WULF TeraWulf	Reiterated by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nick Giles Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.38 +4.6%	$8.00 ➝ $14.00	Buy ➝ Buy
WYY WidePoint	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Buck Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.90 +8.6%	$7.00	Buy ➝ Buy
XOM Exxon Mobil	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Todd	$106.70 +0.2%	$134.00 ➝ $145.00	Overweight ➝ Overweight
XPEV XPeng	Initiated by	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.91 +1.1%		Neutral
XPEV XPeng	Initiated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.91 +1.1%	$19.00	Neutral
XRX Xerox	Initiated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.86 -4.0%	$4.50	Neutral
YEXT Yext	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.80 +8.8%	$10.00	Buy ➝ Buy
ZLNDY Zalando	Upgraded by	Baader Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.71 +1.8%		Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 05:32 AM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings